March 6, 2026

‘In Public Interest’: Bharat Biotech Affirms Covaxin Safety Amid AstraZeneca Debate

'In Public Interest': Bharat Biotech Affirms Covaxin Safety Amid AstraZeneca Debate

Bharat Biotech said all the studies and safety follow-up activities demonstrated “excellent safety record, without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc”

More Stories

‘Won’t Make China-Like Mistake’: US Official Stresses ‘America First’ In India Trade Deal

‘Won’t Make China-Like Mistake’: US Official Stresses ‘America First’ In India Trade Deal

'Disruption In Region Directly Impacts Supply Of Oil And Gas': Rajnath Singh On West Asia Conflict

‘Disruption In Region Directly Impacts Supply Of Oil And Gas’: Rajnath Singh On West Asia Conflict

Bengaluru Set For Warmer Days As Karnataka’s Northern Regions Sizzle

Bengaluru Set For Warmer Days As Karnataka’s Northern Regions Sizzle

You may have missed

‘Won’t Make China-Like Mistake’: US Official Stresses ‘America First’ In India Trade Deal

‘Won’t Make China-Like Mistake’: US Official Stresses ‘America First’ In India Trade Deal

'Disruption In Region Directly Impacts Supply Of Oil And Gas': Rajnath Singh On West Asia Conflict

‘Disruption In Region Directly Impacts Supply Of Oil And Gas’: Rajnath Singh On West Asia Conflict

Bengaluru Set For Warmer Days As Karnataka’s Northern Regions Sizzle

Bengaluru Set For Warmer Days As Karnataka’s Northern Regions Sizzle

How Rajasthan’s Dheeraj Jain Helped 200 Indians Stranded Amid US-Israel-Iran War

How Rajasthan’s Dheeraj Jain Helped 200 Indians Stranded Amid US-Israel-Iran War

From Selfies To Torpedo Strike: Iranian Warship Iris Dena Crew’s Last Moments In India

From Selfies To Torpedo Strike: Iranian Warship Iris Dena Crew’s Last Moments In India